These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3482173)

  • 1. [Incidence of CA 125 antigen in the blood of women with ovarian carcinoma].
    Tosner J; Lacinová V; Louda B; Vanásek J
    Cesk Gynekol; 1987 Nov; 52(9):681-4. PubMed ID: 3482173
    [No Abstract]   [Full Text] [Related]  

  • 2. [New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
    Indraccolo SR; Cecchi A; Thodos A; Brandi S; Carta G
    Ann Ostet Ginecol Med Perinat; 1991; 112(1):36-40. PubMed ID: 1929097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mucinous carcinoma-associated antigen (MCA) in ovarian cancer].
    Hanzal E; Kölbl H; Gitsch G; Bieglmayer C
    Gynakol Rundsch; 1990; 30 Suppl 1():68-70. PubMed ID: 2079303
    [No Abstract]   [Full Text] [Related]  

  • 4. The serum concentrations of TAG-72 antigen measured with CA 72-4 IRMA in patients with ovarian carcinoma. Preliminary data.
    Gadducci A; Ferdeghini M; Ceccarini T; Prontera C; Facchini V; Bianchi R; Fioretti P
    J Nucl Med Allied Sci; 1989; 33(1):32-6. PubMed ID: 2746365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor markers in ovarian cancer].
    Lahousen M
    Jugosl Ginekol Perinatol; 1987; 27(3-4):73-5. PubMed ID: 3481005
    [No Abstract]   [Full Text] [Related]  

  • 6. [A CA 12-5 prognostic score for epithelial ovarian cancers].
    Klein M; Rosen A; Sevelda P; Spona J; Beck A
    Gynakol Rundsch; 1990; 30 Suppl 1():70-2. PubMed ID: 2079305
    [No Abstract]   [Full Text] [Related]  

  • 7. [Carcinoma of the ovary: reliability of its markers].
    Moggian G; Gunelli R; Magrone F; Canali P; Spadazzi AP; Pini PL
    Minerva Ginecol; 1988 Jan; 40(1):9-13. PubMed ID: 3163780
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyst fluid CA 125 levels in ovarian epithelial neoplasms.
    Menczer J; Ben-Baruch G; Moran O; Lipitz S
    Obstet Gynecol; 1993 Jan; 81(1):25-8. PubMed ID: 8416456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Place of carbohydrate antigens in the spectrum of protein tumor markers in patients with tumors at different sites].
    Reznikov IuP; Ul'ianov VI; Variukhin AS; Vanin AI; Vorontsova LP
    Vopr Onkol; 1988; 34(1):51-6. PubMed ID: 3422524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of a cancer antigen, CA 125, associated with ovarian cancer. I. Technical investigation and the reference value].
    Sakurabayashi I; Kawai T; Suzuki M; Tamada T; Sato K; Yonezawa M
    Rinsho Byori; 1984 Dec; 32(12):1345-9. PubMed ID: 6597875
    [No Abstract]   [Full Text] [Related]  

  • 11. [Importance of tumor markers for the diagnosis of ovarian carcinoma].
    Serdev V; Mateeva E; Ankov V; Mikhaĭlova-Todorova S; Ivanova I
    Akush Ginekol (Sofiia); 1987; 26(4):60-4. PubMed ID: 3674327
    [No Abstract]   [Full Text] [Related]  

  • 12. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
    Suzuki H; Teshima K; Noda K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A monoclonal antibody RIA as an antigenic determinant (CA 125) in ovarian cancer patients].
    Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):257-60, 317. PubMed ID: 2417787
    [No Abstract]   [Full Text] [Related]  

  • 14. Roles of CA125 in patients with ovarian cancer--usefulness in periodical monitoring.
    Kawai M; Inagaki S; Yamashita H; Imaizumi H; Kakihara M; Arii Y
    Nihon Gan Chiryo Gakkai Shi; 1988 May; 23(5):1059-67. PubMed ID: 3166484
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
    Crombach G; Zippel HH; Würz H
    Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of serum CA 125 in ovarian cancers.
    Yuan CC; Ng HT; Yeh SH; Jeng FS; Chen SL; Tsai LC
    Zhonghua Yi Xue Za Zhi (Taipei); 1987 Mar; 39(3):153-60. PubMed ID: 3484240
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tumor markers in epithelial ovarian cancer].
    Di Cocco B; Calabretta F; Alghisi F; Salesi N; Bossone G
    Minerva Ginecol; 2003 Aug; 55(4):327-32. PubMed ID: 14581857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of ovarian tumors using the OC 125 monoclonal antibody as a basis for potential in vivo and in vitro applications.
    Mainguené C; Aillet G; Kremer M; Chatal JF
    J Nucl Med Allied Sci; 1986; 30(1):19-22. PubMed ID: 3528419
    [No Abstract]   [Full Text] [Related]  

  • 19. [CA 125--a new characteristic in the diagnosis of ovarian carcinoma].
    Tosner J
    Cesk Gynekol; 1987 Jun; 52(5):381-5. PubMed ID: 3477330
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison of new three tumor markers for pancreatic carcinoma: CA19/9, CA 125 and DuPan 2].
    Ohkura H; Sakawaki T
    Gan No Rinsho; 1985 May; 31(6 Suppl):583-8. PubMed ID: 3861882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.